White E, Papagno L, Samri A, Sugata K, Hejblum B, Henry A
Nat Immunol. 2024; 25(9):1555-1564.
PMID: 39179934
DOI: 10.1038/s41590-024-01931-9.
Escoe B, Fogleman B, Sherertz R
Cureus. 2024; 16(3):e56940.
PMID: 38665746
PMC: 11044190.
DOI: 10.7759/cureus.56940.
Lungu C, Overmars R, Grundeken E, Boers P, van der Ende M, Mesplede T
Viruses. 2023; 15(11).
PMID: 38005913
PMC: 10675771.
DOI: 10.3390/v15112236.
Dragoni F, Kwaa A, Traut C, Veenhuis R, Woldemeskel B, Camilo-Contreras A
J Clin Invest. 2023; 133(21).
PMID: 37698927
PMC: 10617777.
DOI: 10.1172/JCI171097.
Manto C, Castro-Gordon A, Goujard C, Meyer L, Lambotte O, Essat A
Open Forum Infect Dis. 2023; 10(2):ofad067.
PMID: 36846610
PMC: 9945930.
DOI: 10.1093/ofid/ofad067.
Immunogenetic determinants of heterosexual HIV-1 transmission: key findings and lessons from two distinct African cohorts.
Tang J
Genes Immun. 2021; 22(2):65-74.
PMID: 33934119
PMC: 8225584.
DOI: 10.1038/s41435-021-00130-y.
SIV-specific CD8+ T cells are clonotypically distinct across lymphoid and mucosal tissues.
Starke C, Vinton C, Ladell K, McLaren J, Ortiz A, Mudd J
J Clin Invest. 2019; 130(2):789-798.
PMID: 31661461
PMC: 6994127.
DOI: 10.1172/JCI129161.
Cis-regulatory genetic variants in the CCR5 gene and natural HIV-1 control in black South Africans.
Koor G, Paximadis M, Picton A, Karatas F, Loubser S, He W
Clin Immunol. 2019; 205:16-24.
PMID: 31100442
PMC: 6646080.
DOI: 10.1016/j.clim.2019.05.009.
Induction and maintenance of bi-functional (IFN-γ + IL-2+ and IL-2+ TNF-α+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India.
Ponnan S, Pattabiram S, Thiruvengadam K, Goyal R, Singla N, Mukherjee J
PLoS One. 2019; 14(3):e0213911.
PMID: 30921340
PMC: 6438518.
DOI: 10.1371/journal.pone.0213911.
Elevated Expression of miR-19b Enhances CD8 T Cell Function by Targeting PTEN in HIV Infected Long Term Non-progressors With Sustained Viral Suppression.
Yin L, Song C, Zheng J, Fu Y, Qian S, Jiang Y
Front Immunol. 2019; 9:3140.
PMID: 30687333
PMC: 6338066.
DOI: 10.3389/fimmu.2018.03140.
A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation.
Violari A, Cotton M, Kuhn L, Schramm D, Paximadis M, Loubser S
Nat Commun. 2019; 10(1):412.
PMID: 30679439
PMC: 6345921.
DOI: 10.1038/s41467-019-08311-0.
Dynamics in HIV-DNA levels over time in HIV controllers.
Avettand-Fenoel V, Bayan T, Gardiennet E, Boufassa F, Lopez P, Lecuroux C
J Int AIDS Soc. 2019; 22(1):e25221.
PMID: 30629340
PMC: 6327944.
DOI: 10.1002/jia2.25221.
Human Immunodeficiency Virus Type-1 Elite Controllers Maintain Low Co-Expression of Inhibitory Receptors on CD4+ T Cells.
Noyan K, Nguyen S, Betts M, Sonnerborg A, Buggert M
Front Immunol. 2018; 9:19.
PMID: 29403500
PMC: 5786543.
DOI: 10.3389/fimmu.2018.00019.
A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level.
Canoui E, Lecuroux C, Avettand-Fenoel V, Gousset M, Rouzioux C, Saez-Cirion A
Open Forum Infect Dis. 2017; 4(2):ofx064.
PMID: 28584850
PMC: 5450900.
DOI: 10.1093/ofid/ofx064.
Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers.
Chereau F, Madec Y, Sabin C, Obel N, Ruiz-Mateos E, Chrysos G
PLoS One. 2017; 12(4):e0173893.
PMID: 28380038
PMC: 5381858.
DOI: 10.1371/journal.pone.0173893.
Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses.
Teijaro J
Adv Immunol. 2016; 132:135-158.
PMID: 27769506
PMC: 7112115.
DOI: 10.1016/bs.ai.2016.08.001.
Type I interferons in viral control and immune regulation.
Teijaro J
Curr Opin Virol. 2016; 16:31-40.
PMID: 26812607
PMC: 4821698.
DOI: 10.1016/j.coviro.2016.01.001.
Effects of neutralizing antibodies on escape from CD8+ T-cell responses in HIV-1 infection.
Wikramaratna P, Lourenco J, Klenerman P, Pybus O, Gupta S
Philos Trans R Soc Lond B Biol Sci. 2015; 370(1675).
PMID: 26150656
PMC: 4528488.
DOI: 10.1098/rstb.2014.0290.
Immunologic and Virologic Progression in HIV Controllers: The Role of Viral "Blips" and Immune Activation in the ANRS CO21 CODEX Study.
Noel N, Lerolle N, Lecuroux C, Goujard C, Venet A, Saez-Cirion A
PLoS One. 2015; 10(7):e0131922.
PMID: 26146823
PMC: 4493076.
DOI: 10.1371/journal.pone.0131922.
Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like Properties.
Vigano S, Negron J, Ouyang Z, Rosenberg E, Walker B, Lichterfeld M
J Virol. 2015; 89(15):7829-40.
PMID: 25995260
PMC: 4505639.
DOI: 10.1128/JVI.00789-15.